Related Experiment Videos
Fluorescent cellular indicators are extruded by the multidrug resistance protein
L Homolya1, Z Holló, U A Germann
1National Institute of Haematology, Blood Transfusion, and Immunology, Budapest, Hungary.
The Journal of Biological Chemistry
|October 15, 1993
Summary
Multidrug transporter (MDR1) actively exports hydrophobic fluorescent dye precursors, not the dyes themselves. This interaction aids in detecting MDR1-expressing cells and screening drug interactions with MDR1.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Multidrug resistance (MDR) is a major challenge in cancer therapy.
- P-glycoprotein (P-gp), encoded by the MDR1 gene, is a key efflux pump responsible for MDR.
- Fluorescent indicators are widely used in cell biology research.
Purpose of the Study:
- To investigate the interaction between fluorescent dye acetoxymethyl ester (AM) derivatives and the human multidrug transporter (MDR1).
- To determine if MDR1 affects the cellular loading of fluorescent indicators.
- To explore the potential of this interaction for detecting MDR1-expressing cells and screening drug interactions.
Main Methods:
- NIH-3T3 mouse fibroblasts stably expressing human MDR1 were used.
- Comparison of dye extrusion in MDR1-expressing cells versus control cells.
- Inhibition studies using known MDR1 substrates and inhibitors (verapamil, vincristine, etc.).
- ATPase activity assays in isolated cell membranes.
Main Results:
- MDR1-expressing cells actively extruded hydrophobic AM derivatives of fluorescent indicators.
- Dye extrusion was blocked by MDR1 inhibitors and competing substrates.
- Hydrophilic free acid forms of the indicators were not exported by MDR1.
- AM derivatives stimulated MDR1-ATPase activity, while free acid forms did not.
Conclusions:
- MDR1 actively extrudes AM derivatives of fluorescent indicators, potentially before cytoplasmic esterase cleavage.
- This interaction can be exploited for efficient detection of MDR1-expressing tumor cells.
- The findings offer a screening method for evaluating drug interactions with the MDR1 transporter.